Maria H Harris1, Emily Oken2, Sheryl L Rifas-Shiman3, Antonia M Calafat4, Xiaoyun Ye4, David C Bellinger5, Thomas F Webster6, Roberta F White6, Sharon K Sagiv7. 1. Center for Environmental Research and Children's Health, University of California, Berkeley School of Public Health, Berkeley, CA, USA; Division of Epidemiology, University of California, Berkeley School of Public Health, Berkeley, CA, USA. Electronic address: mariaharris@berkeley.edu. 2. Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 3. Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. 4. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Environmental Health, Boston University School of Public Health, Boston, MA, USA. 7. Center for Environmental Research and Children's Health, University of California, Berkeley School of Public Health, Berkeley, CA, USA; Division of Epidemiology, University of California, Berkeley School of Public Health, Berkeley, CA, USA.
Abstract
BACKGROUND: Per- and polyfluoroalkyl substances (PFASs) are suspected developmental toxicants, but epidemiological evidence on neurodevelopmental effects of PFAS exposure is inconsistent. We examined associations of prenatal and childhood PFAS exposure with performance on assessments of cognition in children. METHODS: We included mother-child pairs from Project Viva, a longitudinal Boston-area birth cohort enrolled during 1999-2002. We quantified concentrations of eight PFASs, including perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorohexane sulfonate (PFHxS), in plasma collected from women during pregnancy (median 9.7 weeks gestation) and from children at a visit in mid-childhood (median age 7.7 years). In early childhood (median age 3.2 years) we administered standardized assessments of visual motor skills and vocabulary comprehension, and in mid-childhood we assessed visual motor skills, visual memory, and verbal and non-verbal intelligence. Using multivariable regression, we estimated associations of prenatal and childhood PFAS plasma concentrations with children's cognitive assessment scores, adjusted for relevant covariates including breastfeeding, maternal intelligence, parental education, and household income. Samples sizes ranged from 631 to 971, depending on analysis. RESULTS: Prenatal PFAS concentrations were associated with both better and worse cognitive performance; children with top quartile prenatal concentrations of some PFASs had better visual motor abilities in early childhood and non-verbal IQ and visual memory in mid-childhood, while children with upper quartile prenatal PFOA and PFOS had lower mid-childhood visual-motor scores. In cross-sectional analyses of mid-childhood PFAS concentrations and cognitive assessments, visual-motor scores on the Wide Range Assessment of Visual Motor Abilities (WRAVMA) (standardized mean = 100, standard deviation = 15) were lower among children with higher PFHxS (fourth quartile (Q4) vs. Q1: -5.0, 95% confidence interval (CI): -9.1, -0.8). Upper quartiles of childhood PFOA and PFOS were also associated with somewhat lower childhood WRAVMA scores, but childhood PFASs were not associated with verbal or non-verbal IQ or visual memory. CONCLUSIONS: We present evidence suggesting associations of prenatal and childhood PFAS exposure with lower childhood visual motor abilities. Other results were inconsistent, with higher prenatal PFASs associated in some cases with better cognitive outcomes.
BACKGROUND:Per- and polyfluoroalkyl substances (PFASs) are suspected developmental toxicants, but epidemiological evidence on neurodevelopmental effects of PFAS exposure is inconsistent. We examined associations of prenatal and childhood PFAS exposure with performance on assessments of cognition in children. METHODS: We included mother-child pairs from Project Viva, a longitudinal Boston-area birth cohort enrolled during 1999-2002. We quantified concentrations of eight PFASs, including perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorohexane sulfonate (PFHxS), in plasma collected from women during pregnancy (median 9.7 weeks gestation) and from children at a visit in mid-childhood (median age 7.7 years). In early childhood (median age 3.2 years) we administered standardized assessments of visual motor skills and vocabulary comprehension, and in mid-childhood we assessed visual motor skills, visual memory, and verbal and non-verbal intelligence. Using multivariable regression, we estimated associations of prenatal and childhood PFAS plasma concentrations with children's cognitive assessment scores, adjusted for relevant covariates including breastfeeding, maternal intelligence, parental education, and household income. Samples sizes ranged from 631 to 971, depending on analysis. RESULTS: Prenatal PFAS concentrations were associated with both better and worse cognitive performance; children with top quartile prenatal concentrations of some PFASs had better visual motor abilities in early childhood and non-verbal IQ and visual memory in mid-childhood, while children with upper quartile prenatal PFOA and PFOS had lower mid-childhood visual-motor scores. In cross-sectional analyses of mid-childhood PFAS concentrations and cognitive assessments, visual-motor scores on the Wide Range Assessment of Visual Motor Abilities (WRAVMA) (standardized mean = 100, standard deviation = 15) were lower among children with higher PFHxS (fourth quartile (Q4) vs. Q1: -5.0, 95% confidence interval (CI): -9.1, -0.8). Upper quartiles of childhood PFOA and PFOS were also associated with somewhat lower childhood WRAVMA scores, but childhood PFASs were not associated with verbal or non-verbal IQ or visual memory. CONCLUSIONS: We present evidence suggesting associations of prenatal and childhood PFAS exposure with lower childhood visual motor abilities. Other results were inconsistent, with higher prenatal PFASs associated in some cases with better cognitive outcomes.
Authors: Antonia M Calafat; Zsuzsanna Kuklenyik; John A Reidy; Samuel P Caudill; Jason S Tully; Larry L Needham Journal: Environ Sci Technol Date: 2007-04-01 Impact factor: 9.028
Authors: Arnold Schecter; Noor Malik-Bass; Antonia M Calafat; Kayoko Kato; Justin A Colacino; Tyra L Gent; Linda S Hynan; T Robert Harris; Sunitha Malla; Linda Birnbaum Journal: Environ Health Perspect Date: 2011-12-19 Impact factor: 9.031
Authors: Ann M Vuong; Kimberly Yolton; Changchun Xie; Kim N Dietrich; Joseph M Braun; Glenys M Webster; Antonia M Calafat; Bruce P Lanphear; Aimin Chen Journal: Environ Res Date: 2019-02-16 Impact factor: 6.498
Authors: Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Virginia A Rauh; Morgan Robinson; Kurunthachalam Kannan; Leonardo Trasande; Julie Herbstman Journal: Environ Pollut Date: 2020-03-26 Impact factor: 8.071
Authors: Thea S Skogheim; Gro D Villanger; Kjell Vegard F Weyde; Stephanie M Engel; Pål Surén; Merete G Øie; Annette H Skogan; Guido Biele; Pål Zeiner; Kristin R Øvergaard; Line S Haug; Azemira Sabaredzovic; Heidi Aase Journal: Int J Hyg Environ Health Date: 2019-10-22 Impact factor: 5.840
Authors: Rachel Cluett; Shravanthi M Seshasayee; Lisa B Rokoff; Sheryl L Rifas-Shiman; Xiaoyun Ye; Antonia M Calafat; Diane R Gold; Brent Coull; Catherine M Gordon; Clifford J Rosen; Emily Oken; Sharon K Sagiv; Abby F Fleisch Journal: Environ Health Perspect Date: 2019-08-21 Impact factor: 9.031
Authors: Albeliz Santiago-Colón; Robert Daniels; Dori Reissman; Kristi Anderson; Geoffrey Calvert; Alexis Caplan; Tania Carreón; Alan Katruska; Travis Kubale; Ruiling Liu; Rhonda Nembhard; W Allen Robison; James Yiin; John Howard Journal: Int J Environ Res Public Health Date: 2020-10-06 Impact factor: 3.390
Authors: Marcia P Jimenez; Jessica Shoaff; Marianthi-Anna Kioumourtzoglou; Susan Korrick; Sheryl L Rifas-Shiman; Marie-France Hivert; Emily Oken; Peter James Journal: Am J Epidemiol Date: 2022-01-01 Impact factor: 5.363